UAM_Biblioteca

View Item 

More insights on the use of γ-secretase inhibitors in cancer treatment

Author
López Nieva, María Pilaruntranslated; González-Sánchez, Laura; Cobos Fernández, María Ángelesuntranslated; Córdoba, Raúl; Santos Hernández, Fco. Javieruntranslated; Fernández Piqueras, Joséuntranslated
Entity
UAM. Departamento de Biología
Publisher
Wiley-Blackwell
Date
2020-11-26
Citation
Oncologist 26.2 (2021): e298-e305
ISSN
1083-7159; 1549-490X
DOI
10.1002/onco.13595
Project
Gobierno de España. FIS PI19/00934
Editor's Version
https://doi.org/10.1002/onco.13595
Subjects
Targeted Therapy; Down-Regulation; Challenges; Notch Pathways; Contributes; Resistance; MYC; PF-03084014; Cells; Apoptosis; Broad-Spectrum; Selective γ-Secretase Inhibitors; Secretase Inhibitors; New Resistance Factor; Cell Lymphoblastic Cell Lines; Myc Gene Dosage; T-Cell Lymphoblastic Cell Lines; Selective ?-Secretase Inhibitors; Broad-Spectrum ?-Secretase Inhibitors; Broad-Spectrum Γ-Secretase Inhibitors; Selective Γ-Secretase Inhibitors; Biología y Biomedicina / Biología
URI
http://hdl.handle.net/10486/702302
Rights
© 2020 the Authors

Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
Show full item record

Files in this item

Thumbnail
Size
1.622Mb
Format
PDF

Google™ Scholar:López Nieva, María Pilar - González-Sánchez, Laura - Cobos Fernández, María Ángeles - Córdoba, Raúl - Santos Hernández, Fco. Javier - Fernández Piqueras, José

This item appears in the following Collection(s)